ESC Premium Access

Cardiomyopathy in Fabry disease

Event: ESC Congress 2018
Topic: Fabry´s Disease
Session type: Rapid Fire Abstracts
Date: 26 August 2018
Time: 16:45 - 17:45

Session

6 presentations in this session

Hypertrophy of unaffected cardiomyocytes concurs to severity of cardiomyopathy in female patients with Fabry disease

Speaker: Associate Professor C. Chimenti (Rome, IT)
Thumbnail

Plasma lysoGb3 useful as biomarker in screening for Fabry disease in patients with mild left ventricular hypertrophy

Speaker: Doctor M. Kagimoto (Yokohama, JP)
Thumbnail

Speckle-tracking analysis of right ventricular function in Fabry disease - is left ventricle the only diseased chamber ?

Speaker: Doctor J. Liao (Taipei, TW)
Thumbnail

Treatment of cardiac manifestations in Fabry disease with the oral drug Migalastat: First 12 months results from a cohort of amenable all-comers

Speaker: Mr J. Muentze (Wuerzburg, DE)
Thumbnail

Cardiac magnetic resonance imaging in Fabry cardiomyopathy

Speaker: Professor S. Moiseev (Moscow, RU)
Thumbnail

Novel electrocardiographic parameters for the detection of Fabry Disease - A comparative multi-centre study

Speaker: Doctor M. Namdar (Geneva, CH)
Thumbnail

6 speakers from this session

Associate Professor Cristina Chimenti

Sapienza University of Rome, Rome (Italy)
0 follower

Doctor Minako Kagimoto

Yokohama city university hospital, Yokohama (Japan)
0 follower

Doctor Jo-Nan Liao

Taipei Veterans General Hospital, Taipei (Taiwan)
0 follower

Mr Jonas Muentze

University Hospital Wuerzburg, Wuerzburg (Germany)
0 follower

Professor Sergey Moiseev

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)
0 follower

Doctor Mehdi Namdar

Geneva University Hospitals, Geneva (Switzerland)
4 presentations
0 follower

This platform is supported by

logo Novo Nordisk